Biocon Biologics Inc.
5 drugs in NADAC|2 Generic,3 Brand
Biocon Biologics Inc. lists 5 NDCs in the CMS NADAC file (2 generic, 3 brand), at an average NADAC of $686.67 per unit, with a week-over-week move of +0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
2G / 3B
Avg Price / Unit
$686.6676
$5.92 – $3369.51
Avg 7d Change
+0.05%
Across 4 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
insulin glargine-yfgn market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Insulin Analog therapeutic class
Review the broader class where Biocon Biologics Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Biocon Biologics Inc. make?
Biocon Biologics Inc. lists 5 NDCs in the CMS NADAC file — 2 generic and 3 brand products.
What is the average price of Biocon Biologics Inc. drugs?
The average NADAC across Biocon Biologics Inc.'s portfolio is $686.6676 per unit, ranging from $5.9249 to $3369.5100.
What types of drugs does Biocon Biologics Inc. make?
Biocon Biologics Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Insulin Analog (4), Leukocyte Growth Factor (1).
Has Biocon Biologics Inc. had any drug recalls?
No FDA enforcement recalls are matched to Biocon Biologics Inc. in the openFDA feed.
How has Biocon Biologics Inc.'s pricing changed recently?
Over the past 7 days, 1 Biocon Biologics Inc. product rose and 3 fell, with a portfolio-wide average change of +0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FULPHILA 6 MG/0.6 ML SYRINGE pegfilgrastim-jmdb | $3369.5100 per ML | — |
SEMGLEE (YFGN) 100 UNIT/ML VL insulin glargine-yfgn | $26.0674 per ML | +0.34% |
SEMGLEE (YFGN) 100 UNIT/ML PEN insulin glargine-yfgn | $25.7546 per ML | -0.06% |
INSULIN GLARGINE-YFGN U100 VL insulin Glargine-yfgn | $6.0811 per ML | -0.09% |
INSULIN GLARGINE-YFGN U100 PEN insulin Glargine-yfgn | $5.9249 per ML | -0.01% |